Don’t reinvent the wheel — adapt it. Locate before you correct, because where a failure appears isn’t necessarily where it gets fixed.
- Comparing Advanced Modality Needs, Part 1: Manufacturing
- What Will It Take To Turn CGT Innovation Into Market Success?
- Why CMC Must Shape Critical Decisions Early In Development
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- Closing The Gap Between Modeling And GMP Predictive Control
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
AAV Viral Titering Using Nanoplate-Based Digital PCR
Examine how nanoplate-based digital PCR streamlines AAV titering, providing faster results and greater accuracy, advancing gene therapy development from the lab to the clinic.
-
Method Evaluation Guidance For Transferring A Process
Moving a cell counting method between analyzers in a lab requires evidence of comparability. A structured study of suspension and adherent models tests precision and linearity against defined criteria.
-
Relieving Pressure During Preparation Of A High-Volume sNDA
Managing a complex sNDA under pressure? See how one sponsor achieved an early FDA submission through coordinated publishing, regulatory strategy, and flawless execution.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
It was imperative for a large European CMO producing multiple biologics to select the right product quality and value for each customer to comply with the August 2023 EU GMP Annex 1 revision.
-
Reducing Plastic Waste Using Syringeless Filters
A streamlined approach to HPLC sample preparation can cut plastic waste by up to 79%. Find out how reducing consumables simplifies workflows and supports more sustainable, efficient lab operations.
-
Study: Ensuring Homogeneity In Biopharmaceutical Aliquotation
Tired of manual manipulation risks in biopharmaceuticals? Discover how automated homogenization ensures consistent cell counts and concentration levels, improving patient safety and process reproducibility.
-
Why Compliance-Driven CDMOs Win Sponsor Contracts
Learn how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.
-
Optimize Your Approach To mAb Development
To meet the growing demand for mAbs and their variants, it is important to leverage opportunities for optimization as well as work with suppliers that have the resources to help your workflow thrive.
-
A Comprehensive Solution For Adventitious Agent Testing
Modern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.
-
Expansion Of Human Bone Marrow-Derived MSCs
Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.
NEWSLETTER ARCHIVE
- 11.18.26 -- OPCU: Strengthening Cell And Gene Therapy Programs With Robust Analytics
- 11.18.26 -- What Will It Take To Turn CGT Innovation Into Market Success?
- 11.17.26 -- What If The Body Could Make Its Own Medicine?
- 11.17.26 -- Reducing Tech Transfer Risk In Autologous CAR T Automation
- 11.17.26 -- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- What Will It Take To Turn CGT Innovation Into Market Success?
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

